Navigation Links
Bard® Composix® E/X Mesh

ProductsBard® Composix® E/X Mesh
Company Davol, Inc.
Item Bard® Composix® E/X Mesh
Features 
  • Two distinctly different sides: Polypropylene Bard mesh on one side to promote tissue ingrowth and sub-micronic ePTFE on the other side to minimize adhesions to the prosthesis.
  • Elliptically shaped design: Reduces the need to trim the mesh, saving time.
  • Low Profile: Makes it ideally suited for laparoscopic ventral hernia repairs.
  • Sealed Edge: Prevents exposure of the polypropylene mesh side from contact with the bowel, thus potentially reducing the chances of adhesions around the edge of the prosthesis.
  • Description Bard. The Hernia Repair CompanySM is pleased to announce the latest advancement for ventral hernia repair - Bard Composix E/X mesh. When Bard Composix mesh was introduced in 1997, it was the first ventral hernia repair prosthesis that combined two clinically proven biomaterials, Bard polypropylene mesh and ePTFE, in one product. Bard Composix E/X mesh, the nE/Xt generation in ventral hernia repair prosthesis, has been engineered to include several new customer-focused design features.
    Info Davol, Inc.
    Customer Service: (800) 556-6756
    Web site: http://www.davol.com/

    Related medicine products :

    1. Bard® PerFix® Plug
    2. Bard® Channel Drain
    3. Bard® 4-Channel Urodynamic System
    4. Bard® Magnum® Instrument and Needle
    5. Bard® Magnum® Instrument Needles
    6. Bard® Monopty® Instrument
    7. Bard® MaxCore™ Instrument and Needle
    ... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
    ... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
    ... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
    Inquire...
    Medicine Products:
    (Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business ... and officers for 2017-2018. The annual board election process has been in place since ... basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as ...
    (Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
    (Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
    (Date:4/28/2017)... , ... April 28, 2017 , ... ... 5th anniversary. SearchLight is the premier online modeling resource for fluorescence microscopists and ... 30,000 active users during last 5 years spanning the globe, SearchLight has become ...
    (Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the ... heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to solving ... Countless deodorants flood the aisles that contain harmful chemicals that should be put ...
    Breaking Medicine News(10 mins):
    (Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
    (Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
    (Date:4/19/2017)... EAST HANOVER, N.J. , April 19, 2017 ... study conducted by the National Heart, Lung, and ... Health (NIH) demonstrating that 58% of patients with ... at six months when treated with eltrombopag at ... treatment 1 . The study evaluated three sequential ...
    Breaking Medicine Technology: